MCK vs SKYA vs STVN Stock Comparison

Mckesson, SkyAI and Stevanato Group S.p.A Prices as of Nov 4, 2026 Peers: Industry group
1 more company in this comparison (BTSG) Create a free account to keep reading and compare up to 10 companies.
MCK Mckesson Corp
$1,068.31 +16.6% 1M +26.9% 1Y
Market cap
$123.34B
P/E
26.4x
Revenue (TTM)
$418.79B
Div. yield
0.32%
Drug Distribution Healthcare
6 wins
SKYA SkyAI, Inc.
$2.95 +57.8% 1M -24.7% 1Y
Market cap
$212.68M
P/E
–
Revenue (TTM)
$174.18K
Div. yield
–
Medical Supplies Healthcare
2 wins
STVN Stevanato Group S.p.A.
$13.39 -33.1% 1M -45.9% 1Y
Market cap
$4.06B
P/E
22.4x
Revenue (TTM)
$1.45B
Div. yield
0.37%
Medical Supplies Healthcare
4 wins

Head to Head

12 decided of 12

Mckesson leads on 6 of the 12 questions below (Mckesson 6, Stevanato Group S.p.A 4, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMCKSKYASTVNLeader
Larger companyMarket capitalisation $123.34B $212.68M $4.06B MCK
Cheaper on earningsLower P/E, profitable companies only 26.4x -0.5x 22.4x STVN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.7x 0.0x 20.3x SKYA
Faster revenue growthRevenue growth, trailing twelve months +8.2% +108.0% +12.0% SKYA
More profitableNet margin, trailing twelve months 1.1% -228,220.7% 11.2% STVN
Better return on capitalReturn on invested capital 98.7% — 8.2% MCK
Less leveragedLower net debt / EBITDA 0.4x — 1.1x MCK
Higher dividend yieldTrailing dividend yield 0.32% — 0.37% STVN
Better 1-year returnPrice return, last 12 months +26.9% -24.7% -45.9% MCK
Better 5-year returnAnnualised price return, 5 years +37.0%/yr — -11.3%/yr MCK
Less volatileAnnualised volatility, 1 year 31.3% 105.0% 57.3% MCK
Higher overall scoreMean of the five percentile scores vs peers 61/100 27/100 69/100 STVN

Percentile Scorecard

MCKSKYASTVN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMCKSKYASTVN
Valuation 60 #11 of 26 4 #220 of 229 95 #12 of 229
Growth 63 #10 of 25 4 #213 of 221 43 #126 of 221
Profitability 67 #9 of 25 1 #208 of 209 82 #39 of 209
Financial Health 48 #14 of 26 95 #14 of 240 75 #61 of 240
Shareholder Returns 69 #6 of 17 34 #97 of 146 48 #76 of 146
Overall 61 27 69
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • SKYA ranked among 248 companies in Medical Devices and Diagnostics
  • STVN ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMCKSKYASTVNSPY
1 month +16.6%+57.8%-33.1% -1.0%
3 months +21.7%+130.5%-33.4% -0.4%
6 months +43.7%+56.9%-29.5% +4.5%
Year to date +30.2%+45.3%-33.4% +12.4%
1 year +26.9%-24.7%-45.9% +13.6%
3 years +136.0%-99.9%-49.8% +76.4%
3 years, per year +33.2%-90.0%-20.5% +20.8%
5 years +381.9%—-44.9% +63.7%
5 years, per year +37.0%—-11.3% +10.4%
10 years +717.0%—— +267.7%
10 years, per year +23.4%—— +13.9%

Risk

MeasureMCKSKYASTVNSPY
Volatility, 1Y 31.3%105.0%57.3% 12.8%
Downside volatility, 1Y 27.4%104.5%65.6% 12.7%
Beta vs S&P 500, 1Y -0.192.411.00 1.00
Return / volatility, 1Y 0.86-0.24-0.80 1.06
Max drawdown, 5Y -27.2%-100.0%-62.3% -25.4%
From 52-week high 0.0%-29.9%-46.4% -1.6%
52-week high $1,068.31$4.21$25.00 $779.14
52-week low $725.17$0.95$13.39 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMCKSKYASTVN
P/E now vs peer median 26.4xmedian 25.7x -0.5xmedian 28.5x 22.4xmedian 28.5x
P/S now vs peer median 0.3xmedian 0.3x 1,221xmedian 2.9x 2.8xmedian 2.9x
EV/EBITDA now vs peer median 16.9xmedian 13.9x -0.5xmedian 18.5x 12.5xmedian 18.5x
P/FCF now vs peer median 17.4xmedian 16.6x -1.1xmedian 26.7x 6.9xmedian 26.7x
P/B now vs peer median -31.2xmedian 2.6x 1.4xmedian 2.3x 2.2xmedian 2.3x
PEG now vs peer median 1.66median 1.56 0.01median 0.93 -618.04median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMCKSKYASTVN
Revenue $418.79B $174.18K $1.45B
Gross profit $15.37B $324.68K $422.60M
Operating income $6.69B -$374.36M $241.76M
Net income $5.43B -$397.51M $163.03M
Free cash flow $7.11B -$201.93M $588.03M
R&D – $475.55K $27.87M
EPS (diluted) $40.27 $-5.51 $0.60
Cash & equivalents $6.53B $12.07M $130.31M
Total debt $9.21B – $537.00M
Shares (diluted) 116.70M 72.09M 272.96M
Enterprise value $107.28B $167.38M $3.59B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMCKSKYASTVN
P/E 26.4x -0.5x 22.4x
P/FCF 17.4x -1.1x 6.9x
P/Operating cash flow 16.4x -14.8x 13.5x
P/S 0.3x 1,221x 2.8x
P/B -31.2x 1.4x 2.2x
P/Tangible book -15.6x 16.4x 2.3x
EV/EBITDA 16.9x -0.5x 12.5x
EV/EBIT 18.8x -0.5x 18.4x
EV/Revenue 0.3x 1,152x 3.1x
EV/FCF 17.7x -1.0x 7.6x
EV/Operating cash flow 16.8x -13.9x 14.8x
PEG (3Y EPS CAGR) 1.66 0.01 -618.04

Growth

14 metrics
MetricMCKSKYASTVN
Revenue growth (1Y) 8.2% 108.0% 12.0%
Revenue CAGR (3Y) 12.9% 19.4% 8.8%
Gross profit growth (1Y) 11.8% – 13.9%
Gross profit CAGR (3Y) 7.6% – 5.5%
Operating income growth (1Y) 27.3% -8,055% 11.8%
Operating income CAGR (3Y) 16.1% -240.7% 4.4%
Net income growth (1Y) 28.5% -54,854% 5.0%
Net income CAGR (3Y) 14.2% -268.2% 1.0%
EPS growth (1Y) 24.2% -658.6% 4.3%
EPS CAGR (3Y) 15.9% -100.6% 0.0%
Operating cash flow growth (1Y) 9.3% -356.8% 16.9%
Operating cash flow CAGR (3Y) 15.2% -24.4% 22.5%
Free cash flow growth (1Y) 11.8% -6,031% 7.7%
Free cash flow CAGR (3Y) 16.3% -196.9% -1.4%

Profitability

14 metrics
MetricMCKSKYASTVN
Gross margin 3.7% 186.4% 29.1%
EBITDA margin 1.8% -214,892% 24.6%
Operating margin 1.6% -214,931% 16.7%
Pretax margin 1.6% -221,236% 16.2%
Net margin 1.1% -228,221% 11.2%
FCF margin 1.7% -115,934% 40.6%
Operating cash flow margin 1.8% -8,259% 20.8%
Return on equity – -280.7% 9.1%
Return on assets 6.0% -276.3% 5.4%
Return on invested capital 98.7% – 8.2%
Return on capital employed 42.0% -223.1% –
Asset turnover 4.6x 0.0x 0.5x
Cash conversion (OCF / net income) 1.4x 0.0x 1.8x
Stock comp / revenue – 52,451% –

Financial Health

11 metrics
MetricMCKSKYASTVN
Debt / assets 10.0% – 17.7%
Debt / equity -2.3x – 0.3x
Net debt / EBITDA 0.4x – 1.1x
Debt / FCF 1.3x – 0.9x
Liabilities / assets 104.3% 1.9% 40.2%
Equity / assets -4.3% 98.1% 59.8%
Interest coverage 21.9x – 17.3x
Current ratio 0.9x 5.3x –
Quick ratio 0.5x 4.4x –
Cash ratio 0.1x 4.2x –
Altman Z-score 5.81 30.23 –

Shareholder Returns

7 metrics
MetricMCKSKYASTVN
Dividend yield 0.3% – 0.4%
Net buyback yield 5.4% -0.6% –
Shareholder yield 5.7% -0.6% 0.4%
Payout ratio (earnings) 7.4% – –
Payout ratio (FCF) 5.6% – –
Dividend growth (1Y) 10.5% – –
Dividend CAGR (3Y) 9.8% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMCKSKYASTVN
Forward P/E 22.7xFY2026 0.0xFY2026 20.3xFY2026
EPS, next fiscal year $47.15FY2026 $2,362.06FY2026 $0.66FY2026
EPS growth, next FY +20.6%FY2026 – +4.8%FY2026
EPS growth, the year after +11.0% – +15.2%
Revenue, next fiscal year $444.47BFY2026 $70.01MFY2026 $1.46BFY2026
Revenue growth, next FY +10.2%FY2026 +34,200.1%FY2026 +5.1%FY2026
Revenue growth, the year after +1.5% +17.5% +10.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMCKSKYASTVN
Held by institutions 89.1% – 16.4%
Institutions holding 2,014 – 126
Change in shares held, QoQ -0.7% – +0.4%
Institutions buying 883 – 61
Institutions selling 793 – 52
Buyers to sellers 1.11 – 1.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MCKSKYASTVN
MCK 1.00 -0.10 -0.06
SKYA -0.10 1.00 0.10
STVN -0.06 0.10 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, MCK, SKYA and STVN?

Mckesson (MCK) is the largest by market capitalisation: Mckesson (MCK) $123.34B, SkyAI (SKYA) $212.68M, Stevanato Group S.p.A (STVN) $4.06B.

Which stock is cheaper, MCK, SKYA and STVN?

Stevanato Group S.p.A (STVN) trades on the lowest price-to-earnings ratio (Mckesson (MCK) 26.4x, SkyAI (SKYA) -0.5x, Stevanato Group S.p.A (STVN) 22.4x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (Mckesson (MCK) 22.7x, SkyAI (SKYA) 0.0x, Stevanato Group S.p.A (STVN) 20.3x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: Mckesson (MCK) +8.2%, SkyAI (SKYA) +108.0%, Stevanato Group S.p.A (STVN) +12.0%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (Mckesson (MCK) 1.1%, SkyAI (SKYA) -228,220.7%, Stevanato Group S.p.A (STVN) 11.2%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 98.7%, Stevanato Group S.p.A (STVN) 8.2%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: Mckesson (MCK) +26.9%, SkyAI (SKYA) -24.7%, Stevanato Group S.p.A (STVN) -45.9%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +37.0%/yr, Stevanato Group S.p.A (STVN) -11.3%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Stevanato Group S.p.A (STVN) has the highest dividend yield: Mckesson (MCK) 0.32%, Stevanato Group S.p.A (STVN) 0.37%. SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (Mckesson (MCK) 31.3%, SkyAI (SKYA) 105.0%, Stevanato Group S.p.A (STVN) 57.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MCK, SKYA and STVN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.